Ireland· IE-PA-PA0540/155/001
Plaquenil 200mg Film-coated Tablets
A hydroxychloroquine product containing hydroxychloroquine sulfate, registered in Ireland by Sanofi-Aventis Ireland Limited T/A SANOFI. The same ATC class is registered in 17 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Hydroxychloroquine is registered in 17 of 19 countries.
Countries holding a registration under ATC P01BA02 (hydroxychloroquine), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 10 of them publish a price we can compare per daily dose
Hydroxychloroquine · ATC P01BA02
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of hydroxychloroquine costs, country by country.
Normalised to the WHO defined daily dose (0.516 g), the median price runs from $0.33 in France to $1.28 in Switzerland — a ×3.9 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Hydroxychloroquine · price per daily dose (0.516 g)
USD · FX 28 Sept 2026
- CH Switzerland$1.28
- IT Italy$0.45
- FR France$0.33
The record
At a glance
HPRA (Ireland)- Active substance
- Hydroxychloroquine sulfate
- Manufacturer
- Sanofi-Aventis Ireland Limited T/A SANOFI
- Country
- Ireland (IE)
- ATC code
- P01BA02
- ATC class
- Hydroxychloroquine
- Defined daily dose
- 0.516 g, O
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA0540/155/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
748 interactions on record for hydroxychloroquine.
Graded by severity as the source publishes them — 220 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Hydroxychloroquine · interactions on record
748 records
- 220 severe
- 278 moderate
- 6 minor
- 244 info
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- OndansetronA04AA01severe
- GranisetronA04AA02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Hydroxychloroquine in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesHydroxychloroquine sulfateAphena Pharma Solutions - Tennessee, LLC
- SpainDUPLAXIL 200 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGLaboratorios Gebro Pharma S.A.
- NetherlandsHydroxychloroquinesulfaat 200 mg Focus, filmomhulde tablettenFocus Care Pharmaceuticals B.V.
- PolandAutokilaTarchomińskie Zakłady Farmaceutyczne "Polfa" S.A.
- IcelandPlaquenilSanofi-aventis Norge AS
- SwitzerlandHydroxychloroquine Zentiva
- NorwayPimaxiroMedical Valley Invest AB
- SwedenPimaxiro 200 mg Filmdragerad tablettMedical Valley Invest AB
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Hyplaxy
- Belgium · Plaquenil
- Bulgaria · Моривид
- Cyprus · Plaquenil
- Czechia · Plaquenil
- Germany · Hydroxychloroquin Heumann, Hydroxychloroquin Ipca
- Denmark · Pimaxiro, Plaquenil
- Estonia · Hydroxychloroquine Auxilia, Plaquenil
- Spain · Dolquine, Duplaxil
- Finland · Oxiklorin
- France · Plaquenil
- United Kingdom (Northern Ireland) · Hydroxychloroquine Sulfate Accord-Uk, Hydroxychloroquine Sulfate Blackrock Pharmaceuticals
- Greece · Plaquenil
- Croatia · Hyplaxy
- Hungary · Hidroxiklorokin Meditop, Plaquenil
- Iceland · Plaquenil
- Italy · Idrossiclorochina Aurobindo, Idrossiclorochina Doc
- Lithuania · Plaquenil
- Luxembourg · Plaquenil
- Latvia · Plaquenil
- Malta · Hydroxychloroquine Sulfate Ipca Laboratories Uk, Hydroxychloroquine Sulfate Ipca Produtos Farmaceuticos Unipessoal Lda
- Netherlands · Hydroxychloroquine Sulfate Aurobindo, Hydroxychloroquinesulfaat Cf
- Norway · Pimaxiro, Plaquenil
- Poland · Autokila, Hydroquenin
- Portugal · Hidroxicloroquina Basi, Hidroxicloroquina Generis
- Romania · Hidroxiclorochina Atb, Plaquenil
- Sweden · Pimaxiro, Plaquenil
- Slovenia · Hyplaxy
- Slovakia · Plaquenil
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/dcf46111-043c-496e-ae16-e9e0eab12175 GET /v1/drugs/dcf46111-043c-496e-ae16-e9e0eab12175?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Film-coated tablet",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"P01BA",
"P01BA02"
],
"strength": null,
"pa_number": "PA0540/155/001",
"substances": [
"Hydroxychloroquine sulfate"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Marketed",
"authorised_at": "01/04/1977",
"dispensing_status": "Product subject to prescription which may be renewed (B)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about hydroxychloroquine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.